CAROL GARFEIN: Open Payments
NPI 1831272202 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 6 payments from 3 companies in 2025. Trend: 2023 $254 · 2024 $250 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $476 |
| Otsuka America Pharmaceutical, Inc. | 1 | $138 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
Products named: UZEDY, REXULTI, COBENFY.
Industry payments across NY — which companies pay providers there.
